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A Population-Based Study of Acquired Bilateral
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Bei-Qing Wang1,3, Zheng-Yu Shen1,3, Ye Fei1, Hong Li2, Jian-Hang Liu1, Hui Xu1, Zhen Zhang1,
Xiao-Hong Yu1 and Xiang-Dong Chen1
Acquired bilateral nevus-of-Ota-like macule (ABNOM) is a common skin dyspigmentation in Asian females.
Although its clinical characteristics are well defined, its epidemiology and pathogenesis remain unclear. A large
population-based cross-sectional study was conducted to determine the prevalence and risk factors of ABNOM.
A total of 8,680 subjects (ages ranging from newborn to 99 years old; 54% female) were selected from urban
areas in Shanghai, China, using a multistage sampling method. All participants (response rate¼ 97%) were
interviewed and examined for the presence of various pigmentary disorders by board-certified dermatologists.
ABNOM was found in 2.5% of the study population (0.5% of males and 4.2% of females), and 90% of cases
observed were female. In females, prevalence rose after the age of 15 years and sharply declined after the age of
50 years, with nearly half of the cases observed within ages 45–55 years (prevalence¼ 8.5%). Age, contraceptive
use, and sun exposure were independently associated with ABNOM. Women with ABNOM were less likely to
have facial nevomelanocytic nevi and seborrheic keratoses. These findings indicate that sex hormone alteration
and UV exposure may independently have an important role on the pathogenesis of ABNOM.
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INTRODUCTION
Acquired bilateral nevus-of-Ota-like macules (ABNOM) is
a common pigmentary disorder that has been clinically
described for only two decades, documented for the first time
in 1984 (Hori et al., 1984). In addition, Sun et al. (1987)
reported this dermatological lesion as nevus fusco-ceruleus
zygomaticus. This common skin lesion is usually refractory to
conventional treatment. Owing to increased cosmetic con-
cern and limited treatment options, ABNOM often frustrates
both patients and clinicians.
Although there is an abundance of literature on ABNOM,
the majority of the studies are focused on dermatological
characteristics and treatment options (Wei et al., 1997; Li and
Gong, 1999; Ee et al., 2006). There have been very few
epidemiological studies on the disorder, and the pathogenesis
of ABNOM is poorly understood. To identify the underlying
risk factors of ABNOM, we conducted this large population-
based study in China to elucidate the epidemiology of
ABNOM.
RESULTS
Prevalence of ABNOM in the study population
With a response rate of 97%, 8,680 subjects (54% female)
aged from newborn to 99 years (mean age 44.4 years) were
evaluated. ABNOM was found in 21 males (mean age of 45.8
years, ranging from 13 to 58 years old) and 196 females
(mean age of 45.9 years, ranging from 5 to 83 years old), with
an overall prevalence of 2.5% that was higher than the
prevalence of nevus of Ota (19 cases, 0.22%; data not
shown). Prevalence in females was significantly higher than
that in males (4.2 vs 0.5%; Po0.0001), as 90.3% of cases
were observed in females. Figure 1 shows a locally weighted
scatter plot with smoothed curves of the ABNOM prevalence
rate by age in both males (thin line) and females (thick line). A
bell shape or quadratic trend was observed in females. The
prevalence rate in women started increasing after the age of
15 years, reaching a peak in the late forties (above 7%), and
was followed by a sharp decline after the age of age 50 years.
In the male group, the same fluctuation was seen between
those in their mid-thirties and late fifties; however, the pattern
was unclear.
Factors associated with ABNOM in the female population
In light of the fact that ABNOM cases were predominantly
female, further analyses were focused on this population.
Female characteristics are summarized in Table 1. Age was
significantly associated with ABNOM, as the prevalence rate
was lower (p1%) in both younger (o25 years) and older
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(X75 years) women, and the highest prevalence (8.5%) was
observed in those aged 45–55 years old. Among women with
ABNOM (Figure 2), nearly half of them were between the
ages of 45 and 54.9 years old, and median age (interquartile
range) for ABNOM women was 46 (30–57) years old. Among
21 cases observed in male, 15 of them were observed in age
between 45 and 55 years old (data not shown).
Other factors including sun exposure, contraceptive use,
and pregnancy were also potentially associated with a
high risk of developing ABNOM. In contrast, concurrence
with other pigmentary disorders such as melasma, facial
nevomelanocytic nevi, and facial seborrheic keratoses (SK)
was either negatively or not associated with ABNOM.
Multivariate analysis revealed that age, contraceptive use,
and sun exposure were independently associated as risks of
having ABNOM (Table 2). Compared with age younger than
18 years, the odds ratios of having ABNOM significantly
increased after the age of 25 years, and reached the highest at
the ages of 45–55 years (odds ratio, 95% confidence interval:
14.2, 3.7–54.5). The odds ratios for sun exposure and contra-
ceptive use were two times higher than their counterpart
(Po0.05). However, women with facial nevomelanocytic
nevi and facial SK were less likely to have ABNOM. Lastly,
there was no association found between sun exposure and
ABNOM in the male population; ABNOM in men with sun
exposure (7 cases) was 0.48% and that in men without sun
exposure (14 cases) was 0.56% (data not shown).
DISCUSSION
To our knowledge, this is a previously unreported large
population-based study of ABNOM in all age groups. In this
study, 8,680 subjects were selected in Shanghai, China,
based on multistage sampling method. More than 90% of
ABNOM cases were observed in the female population and
the prevalence in women started increasing after the age of
15 years and sharply declined after the age of 50 years, which
is in accordance with the change of female hormone in vivo.
In addition to the age effect, contraceptive use and sun
exposure were also independently associated with increased
risk of ABNOM.
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Figure 1. Acquired bilateral nevus-of-Ota-like macules (ABNOM)
prevalence rate by age in male (thin line) and female (thick line)
populations.
Table 1. Characteristics of female subjects
Observed Weighted
Factor
No. of
women
No. of
cases (%)
%
Cases P-value1
Overall 4,683 196 (4.2) 4.2
Age
Median (range) 46.0 (1–95)
o18 374 3 (0.8) 0.9 o0.0001
18–24.9 420 5 (1.2) 1.1
25–34.9 658 23 (3.5) 3.3
35–44.9 690 40 (5.8) 5.8
45–54.9 1,139 95 (8.3) 8.5
55–64.9 644 17 (2.6) 2.6
65–74.9 403 11 (2.7) 2.7
X75 355 2 (0.6) 0.6
Mixed pigmentary
Melasma
Yes 495 23 (4.7) 4.3 0.89
No 4,165 173 (4.2) 4.2
Nevomelanocytic nevi
Yes 2,153 73 (3.4) 3.4 0.01
No 2,501 123 (4.9) 4.9
Seborrheic keratoses
Yes 1,316 30 (2.3) 2.3 o0.0001
No 3,324 166 (5.0) 5.0
Sun exposure
Yes 445 32 (7.2) 7.0 0.001
No 4,213 164 (3.9) 3.9
Contraceptive use
Yes 316 27 (8.5) 8.7 o0.0001
No 4,359 169 (3.9) 3.9
History of skin allergy
Yes 127 9 (7.1) 6.9 0.10
No 4,534 187 (4.1) 4.1
History of pregnancy
Yes 3,610 174 (4.8) 4.8 0.0001
No 1,054 22 (2.1) 2.1
1From weighted samples.
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Dermal melanocytosis includes several benign pigmented
diseases. Some of them, such as Mongolian spot, nevus of Ito,
or nevus of Ota, are often present at birth; whereas ABNOM
or blue nevus are acquired skin pigmentations (Richard et al.,
2000). Although ABNOM was first reported only 25 years
ago, it is a common acquired facial dermal melanocytosis
with distinctive features. This skin disease has recently
received a great deal of attention because of its cosmetic
problems for patients.
ABNOM acquired its name because of its histological
similarities to nevus of Ota. These two skin conditions present
with light brownish dermal melanocytes of bipolar, oval,
or irregular shape when observed under a high-power light
microscope. In most cases, these cells are parallel to the
epidermis, scattered in the upper and middle portions of the
dermis. However, recent research has found a difference
between the melanocytes in these two disorders. Melano-
cytes in ABNOM are dispersed in a perivascular fashion,
whereas melanocytes in nevus of Ota are evenly distributed
throughout the dermis (Lee et al., 2004). Higher-power-field
light microscopy further demonstrates that the light brownish
dermal melanocytes consist of pinpoint-sized granules, and
use of a transmission electron microscope reveals that these
melanocytes are bipolar or irregular dendritic cells with many
cytoplasmic pigment granules.
Presently, there are four potential mechanisms to explain
the origin of the melanocytes in ABNOM: (1) the early brown
lesions reflect melanocytes at the basal layer of the epidermis,
and their subsequent migration into the dermis results in a
darker bluish-gray hue, which supports the notion that the
melanocytes descend from the epidermis (Hori et al., 1984);
(2) the appearance of latent dermal melanocytosis is triggered
by either dermal inflammation or atrophy of the epidermis
and/or dermis; this theory of reactivation of preexisting
melanocytes is consistent with the presence of dermal
melanocytes in uninvolved skin near the pigmented macules
(Mizushima et al., 1998); (3) the migration of hair bulb
melanocytes; or (4) the reactivation of existing melanocytes,
which may contribute to pigmentary change (Rubin et al.,
2001).
Although ABNOM can be treated by laser successfully, the
equipment is available for the most part only in urban cities
or large medical centers. In addition, the cost of this
expensive procedure is prohibitive for many women, as this
cosmetic treatment is often not covered by medical insur-
ance. This common skin condition affects the quality of life of
many women such as social activity.
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Figure 2. Percent distribution of female acquired bilateral nevus-of-Ota-like
macules (ABNOM) cases according to different age groups. Median
(interquartile) age of ABNOM women is 46 (30–57) years.
Table 2. Factors associated with ABNOM in females
Factor
Unadjusted
OR (95% CI)
Adjusted
OR1 (95% CI)
Age (Years)
o18 1 1
18–24.9 1.32 (0.31, 5.61) 1.39 (0.32, 6.04)
25–34.9 3.98 (1.18, 13.4) 4.42 (1.15, 16.9)
35–44.9 7.13 (2.19, 23.3) 8.99 (2.34, 34.5)
45–54.9 10.7 (3.37, 34.2) 14.2 (3.68, 54.5)
55–64.9 3.09 (0.90, 10.7) 4.55 (1.11, 18.6)
65–74.9 3.24 (0.89, 11.6) 6.05 (1.37, 26.7)
X75 0.74 (0.12, 4.46) 1.51 (0.19, 11.8)
Nevomelanocytic nevi
Yes 0.69 (0.51, 0.93) 0.60 (0.44, 0.82)
No 1 1
Seborrheic keratoses
Yes 0.45 (0.30, 0.66) 0.44 (0.28, 0.70)
No 1 1
Sun exposure
Yes 1.86 (1.25, 2.76) 1.99 (1.29, 3.08)
No 1 1
Contraceptive use
Yes 2.36 (1.53, 3.63) 2.11 (1.34, 3.30)
No 1 1
History of skin allergy
Yes 1.73 (0.86, 3.49) 1.57 (0.74, 3.36)
No 1 1
History of pregnancy
Yes 2.40 (1.53, 3.80) 0.80 (0.42, 1.49)
No 1 1
Abbreviations: ABNOM, acquired bilateral nevus-of-Ota-like macules; CI,
confidence interval; OR, odds ratio.
1Adjusted other factors in same multivariate model.
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In our survey, we found that the overall prevalence rate of
ABNOM in Shanghai was 2.5 and 4.2% in females. The
prevalence rate in our study was lower than those reported
in previous studies, as their samples were selected from
hospitals or outpatient dermatology clinics (Li and Gong,
1999). As all of the patients were seen or referred to the
dermatological clinic because of certain skin conditions, it is
not surprising that ABNOM was more commonly found in
their selected study population. A low prevalence rate of
0.8% reported by Sun et al. (1987) may have been because
of the small sample size and the lack of a standardized
definition for the condition. Thus, their particular study
setting does not reflect prevalence in the general population.
Interestingly, our survey found that ABNOM was more
prevalent than nevus of Ota (0.22%), supporting that more
research attention should be paid on ABNOM because of its
potential value. This is further supported by the large impact
that ABNOM has on the social life of patients owing to its
detrimental cosmetic effect, which has spurred a growing
demand for its treatment.
Findings from this study indicate that the development
of ABNOM may be associated with female sex hormones,
based on the finding that the prevalence of ABNOM started
increasing after puberty and sharply declined after meno-
pause, which is in accordance with the change of female
hormone levels over a woman’s lifespan. Moreover, the
association with the use of contraceptives and history of
pregnancy is also indicative of the involvement of sex
hormones. Evidence from this study is in agreement with
the hypothesis that estrogen or progesterone activates
preexisting immature melanocytes (Ee et al., 2006). Estrogen
and progesterone have also been shown to activate melano-
cytes in melasma (Rubin et al., 2001). However, researchers
have recently found that the expression of androgen receptors
increase in ABNOM lesions, whereas estrogen and proges-
terone receptors do not (Long et al., 2010).
Consistent with other publications (Ee et al., 2006), we
also observed the effect of sun exposure on ABNOM.
However, the effect was only significant in females and not
in males, indicating that sex hormones and UV exposure may
synergistically contribute to the pathogenesis of ABNOM.
Sun exposure has also been associated with many other skin
pigmentation conditions such as SK (Richard et al., 2000).
Several reports have indicated that patients with ABNOM
were also likely to have other pigment disorders such as
melasma and lentigines (Kunachak et al., 1999; Polnikorn
et al., 2000; Lam et al., 2001). Inconsistent with these find-
ings, we found that melasma does not commonly coexist with
ABNOM, and women with ABNOM were less likely to have
facial nevomelanocytic nevi and SK. Our study findings have
shown that facial nevomelanocytic nevi often occurred in
middle age, and facial SK mainly appeared in older age,
whereas the occurrence of ABNOM increased after puberty
and declined after the age 50 years, suggesting that the
pathogenesis of these pigmentary diseases are very different.
Two limitations of this study stemmed from the study
design. Family histories of those with the same lesions
(15.2%) were only obtained from identified ABNOM cases.
Families were not recorded or grouped together; therefore,
we are unable to evaluate the influence of heredity on
ABNOM. Onset time, time span of the condition, and
treatment status were also not obtained at the time of the
interview; therefore, the actual prevalence rate may differ
from the observed prevalence.
In summary, the findings derived from this large epide-
miological study have provided an insight into the epide-
miology of ABNOM and its potential relationship with
various risk factors. Future studies on the pathogenesis of
ABNOM, such as cell biology research, are needed to
determine the conclusive causes of the disease and lead to
therapeutic and preventive strategies.
MATERIALS AND METHODS
Sampling and study population
This population-based cross-sectional study was conducted in
Shanghai, China, between May 2005 and December 2005.
Shanghai, the largest city in China, is located in the southern region
of the country. According to the Shanghai statistical year book
(www.stats-sh.gov.cn), there were a total of 13.6 million registered
permanent residents in 2005, of which 6.2 million people lived in
9 urban districts, with the remaining 7.4 million people living in
7 rural districts and one county. Estimating the ABNOM prevalence
rate at 5%, a sample size of 7,300 would represent the population
with a reliability of 95% (Dean et al., 1990). With consideration of a
15% nonresponse rate and an additional 5% from unexpected
issues, we aimed to reach 9,000 people for this prevalence and risk
factor study. A multistage sampling procedure was used to attain the
desired study sample size. To reduce travel difficulties, the sampling
was restricted to urban districts. We randomly selected three districts
from the nine urban districts in Shanghai, and then three neighbor-
hood communities were selected from each of the three selected
districts. Within each of the three selected neighborhood com-
munities, 10 residential buildings were selected. The number of people
from each selected district was 887,448 from Changning district,
309,992 from Jing’an district, and 784,967 from Hongkou district.
Overall, 9,015 individuals were approached from 90 residential
buildings in three districts, with 8,739 individuals (97% response
rate) agreeing to participate in the study and provide information on
their age (those younger than 1 year were recorded as 1 year),
gender, contraceptive use, pregnancy history, allergic dermato-
logical disorders (for example, urticaria, eczema, etc), and intense
sun exposure defined as 430 hours of outdoor exposure per month
without any protection. Final analysis included 8,680 subjects who
had confirmed diagnosis and gender information.
Procedure
At 1 month before starting the large field investigation, pamphlets
describing the study purpose, procedure, and contact information
were distributed in the targeted residential areas. At 1 week before
the interview, a note explaining the study objective, procedure,
schedule, and contact information was posted on the front door of
each targeted home. In addition, subjects were asked to provide their
contact information if rescheduling was needed. At 1 day before the
interview, community representatives contacted the study subjects to
ensure that they were available for the interview. All interview and
dermatological examinations were performed in accordance with
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the Declaration of Helsinki Principle after obtaining oral consent
from adult participants. Oral permission from direct relatives or
guardians was also required for examining both children aged o18
years of age and disabled adults. The study was approved by the
Science and Technology Commission of Shanghai Municipality in
Shanghai, China.
ABNOM examination
All participants were interviewed and examined in person for the
presence of ABNOM or other pigmentary disorders, including facial
nevomelanocytic nevi, facial SK, melasma, and nevus of Ota, by
board-certified dermatologists from the Shanghai Ninth Hospital
affiliated with Shanghai Jiao Tong University School of Medicine.
ABNOM was identified according to its distinctive clinical
features, as defined by previous studies (Hori et al., 1984). The
lesions were typically found on the malars, forehead, nose, temples,
and eyelids, with the characteristic colors of yellow-brown, blue-
brown, or slate-grey, and the lack of mucosal involvement (Figure 1)
(Kuroki et al., 1999). Nevus of Ota was diagnosed by its frequent
unilateral or unsymmetrical location on the face, the conjunctiva,
and skin of the eye supplied by the first and second branch of the
trigeminal nerve, as well as the sclera, ocular, and buccal mucosa,
which may also be involved (Park et al., 2009). Another important
differential diagnosis was melasma. Melasma often appears as
yellow or brown patches. Muffle could be involved in melasma,
which cannot be seen in ABNOM, and the shape and location of
melasma can sometimes change. All cases were diagnosed by the
dermatologists through dermatological examination and history
taking. If it was necessary, special equipment, such as a 365-nm
Wood lamp, was used for close examination. A structured
questionnaire was used to collect information on possible risk
factors such as age, gender, sun exposure, contraceptive use,
pregnancy history, skin allergy history (that is, history of allergic
dermatological disorders), and smoking status.
Statistical data analysis
All analyses were performed using SUDAAN software release 9.0
(RTI International, Research Triangle Park, NC) to account for
sampling design and weights unless otherwise noted. We used
multistage sampling with design weight to determine the probability
of selection at each stage, which was the inverse of the sampling
fraction for urban districts and the inverse of the sampling fraction for
each selected district. All presented estimations were weighted
according to the sampling fraction. First, the relationships between
ABNOM prevalence and age in both male and female participants
were graphically explored in locally weighted smoothing curves,
also called Lowess curves (Cleveland, 1979). As ABNOM was
predominately observed in women, further analyses were focused on
the female population. Cross-tabulations were used to estimate the
proportions of ABNOM occurrence in each age category, as well as
in other measured factors in the female population. A w2-test was
used in univariate analysis; variables with Po0.10 in univariate
analysis were included in the model for multivariate logistic
regression analysis. All reported P-values were two sided and a
value of Po0.05 was considered statistically significant.
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